Bank Of America Corp Dexcom Inc Call Options Transaction History

Bank Of America Corp

9 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q3 2024 Nov 14, 2024	SELL	$64.0 - $116.06 $2.5 Million - $4.54 Million	-39,100 Reduced 21.44%	143,300 $9.6 Million
Q2 2024 Aug 14, 2024	BUY	$110.31 - $140.45 $17.2 Million - $22 Million	156,300 Added 598.85%	182,400 $20.7 Million
Q1 2024 May 15, 2024	SELL	$114.22 - $140.1 $6.81 Million - $8.35 Million	-59,600 Reduced 69.54%	26,100 $3.62 Million
Q4 2023 Feb 14, 2024	SELL	$75.49 - $124.16 $3.99 Million - $6.56 Million	-52,800 Reduced 38.12%	85,700 $10.6 Million
Q2 2023 Aug 14, 2023	BUY	$112.47 - $130.98 $15.6 Million - $18.1 Million	138,500 New	138,500 $17.8 Million
Q4 2022 Feb 10, 2023	SELL	$84.98 - $122.67 $1.71 Million - $2.47 Million	-20,100 Reduced 99.01%	200 $22,000
Q3 2022 Nov 14, 2022	SELL	$76.35 - $94.18 $595,530 - $734,604	-7,800 Reduced 27.76%	20,300 $1.64 Million
Q2 2022 Aug 12, 2022	BUY	$67.99 - $132.89 $1.44 Million - $2.82 Million	21,200 Added 307.25%	28,100 $2.09 Million
Q3 2021 Nov 15, 2021	BUY	$106.71 - $143.18 $736,299 - $987,942	6,900 New	6,900 $3.77 Million

1,013

351M

5.51M

5.6M

Ticker DXCM
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 386,257,984
Market Cap $29.3B
Description
DexCom, Inc., a medical device company, focuses on the design, development, and commercialization of continuous glucose monitoring (CGM) systems in the United States and internationally. The company provides its systems for use by people with diabetes, as well as for use by healthcare providers. Its products include DexCom G6, an integrated CGM ...

Get notified when there are updates to the investment portfolio of Bank Of America Corp , based on Form 13F filings with the SEC.

Stay updated on Bank Of America Corp with notifications on news.